Autres langues IRADIMED CORPORATION

Actions

IRMD

US46266A1097

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 18/09/2026			Varia. 5j.	Varia. 1 janv.
82,12 ^USD	-0,75%		+0,31%	-15,58%

31/07	IRADIMED CORPORATION publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
31/07	Transcript : IRADIMED CORPORATION, Q2 2026 Earnings Call, Jul 31, 2026

Autres langues

31/07	IRADIMED CORPORATION Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
31/07	Iradimed Corporation Declares Regular Quarterly Cash Dividend for the Second Quarter Ended June 30, 2026, Payable on August 28, 2026
31/07	Iradimed Corporation Provides Earnings Guidance for the Third Quarter and Reaffirms Earnings Guidance for the Full Year of 2026
31/07	IRadimed Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook, Reaffirms 2026 Guidance
31/07	(IRMD) IRadimed Expects 2026 Revenue Range $91M to $96M, vs. FactSet Est of $91.2M
31/07	Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q2 Adjusted EPS $0.46, vs. FactSet Est of $0.44
31/07	(IRMD) IRADIMED CORPORATION Expects Q3 Adjusted EPS Range $0.54 - $0.59
31/07	(IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.09 to $2.24, vs. FactSet Est of $2.08
31/07	(IRMD) IRADIMED CORPORATION Expects Q3 Revenue Range $23.0M - $24.5M
31/07	Earnings Flash (IRMD) IRADIMED CORPORATION Reports Q2 Revenue $20.5M, vs. FactSet Est of $20.4M
31/07	IRadimed: Q2 Earnings Snapshot
31/07	IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results
27/07	IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
24/07	IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026
04/06	Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing
28/05	Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing
20/05	IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
01/05	IRADIMED CORPORATION Reports Earnings Results for the First Quarter Ended March 31, 2026
01/05	Iradimed Q1 Non-GAAP Earnings, Revenue Rise
01/05	IRadimed: Q1 Earnings Snapshot
01/05	(IRMD) IRadimed Expects 2026 Revenue Range $91.0M to $96.0M, vs. FactSet Est of $92.3M
01/05	(IRMD) Iradimed Expects 2026 Adjusted EPS Range $2.06 to $2.21, vs. FactSet Est of $2.08
01/05	(IRMD) IRADIMED CORPORATION Expects Q2 Revenue Range $20.0M - $21.0M
01/05	(IRMD) IRADIMED CORPORATION Expects Q2 Adjusted EPS Range $0.44 - $0.48
01/05	Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Adjusted EPS $0.49 per Share, vs. FactSet Est of $0.45